Chapter 8: Enzyme Kinetics & Reaction Rates

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome to the Deep Dive.

If you've ever wondered what makes life tick, or maybe more accurately, what makes life speed up, today we're diving into the absolute core of cellular machinery.

We are plunging into enzyme kinetics, the essential quantitative science that governs the speed of life.

Yeah, that's exactly right.

Our whole mission today is to give you a complete shortcut to understanding these mechanics.

We're looking at the quantitative measurement of enzyme catalyzed reactions.

And what affects them.

And all the factors that dictate their speed, and really why knowing those specific measurements is so critical.

And the reason this isn't just, some abstract theory, is its massive biomedical importance.

Understanding how fast specific biochemical reactions happen allows us to analyze, diagnose, and most importantly, treat disease.

When you look at therapeutic agents drugs, they almost always work by selectively jamming up or accelerating very specific enzymatic processes.

Exactly.

This isn't just theoretical biochemistry, this is clinical practice.

For instance, when a doctor detects a surge of specific enzymes in your bloodstream, like those indicating serious damage to the liver, or myocardial infarction, a heart attack,

those enzymes serve as crucial clinical indicators.

The only way we can interpret those markers accurately and quickly is by understanding the precise kinetic properties of those molecules.

Okay, let's unpack this first big concept.

We really have to separate two ideas that often get mashed together, thermodynamics and kinetics.

It's the difference between asking, can this reaction happen, versus asking how fast will it happen?

That's a perfect way to frame it.

Thermodynamics is all about the can, the direction, and the final equilibrium state.

And that's all governed by the Gibbs free energy change.

Okay.

If that value is negative, the reaction is favored, or you know, spontaneous.

But here's the fundamental takeaway.

The Gibbs free energy value gives you no information whatsoever, but how long it will take for that reaction to occur.

So it tells us where we eventually end up, the balance of substrates versus products at the very end, which we quantify with the equilibrium constant.

Right.

And where the rate comes in is with the activation energy.

Think of the reaction like a journey over a mountain range.

The Gibbs free energy, that's just the elevation difference between your starting valley and your ending valley.

Okay.

But the activation energy is the height of the mountain pass, you have to climb to get from one to the other.

That mountain pass is what biochemists call the transition state.

Precisely.

It's that highly unstable fleeting moment where bonds are half broken and half formed.

It's an energy barrier that has to be surmounted.

And the rate of your reaction is inversely related to the height of that barrier.

The lower the pass, the faster you go.

The lower the pass, the faster the reaction.

Which is pretty much the job description of an enzyme.

Absolutely.

Enzymes accelerate reaction rates by doing one thing.

They lower that mountain pass, they stabilize that fragile transition state, maybe by changing the substrate shape, introducing some charges, or using acid -based chemistry.

I see.

But, and this is crucial, since the enzyme emerges unchanged, they only change the height of the pass, not the starting or ending elevations.

So they don't change the overall energetics?

No.

Enzymes have no effect on the overall Gibbs free energy or the equilibrium constant.

They just get you to the exact same destination much, much faster.

That is just such an elegant piece of chemistry.

So moving on to the factors that determine rate.

This comes down to basic collision theory, right?

That's it.

Molecules have to collide, and they have to collide with enough kinetic energy to get over that barrier.

So anything that increases the frequency or the energy of those collisions should increase the rate.

And temperature is the most intuitive example.

You raise the temperature, you increase kinetic energy, you increase collision frequency, and things speed up.

We even quantify this with something called the temperature coefficient, the Q10, where a reaction rate often doubles for every 10 degrees Celsius rise.

But biologically, we face a ceiling.

For humans, there's a delicate balance.

While heat speeds up the chemistry, too much heat, say, above 45 to 55 degrees Celsius.

Yeah, that's dangerous.

It causes the enzyme protein to denature, to unfold.

And when the structure is gone, the catalytic activity is gone.

The rate just drops to zero.

That's why high fevers are so dangerous.

And then there's reacting concentration.

It's simple.

If you have more stuff to react, the rate is naturally going to be higher.

It's directly proportionate to the concentrations of the reacting molecules.

And we define this with a rate expression, where the total kinetic order is the sum of the exponents on those concentration terms.

Exactly.

That sounds like it could get complicated, though, if you have a reaction with five different things coming together.

How do researchers simplify that in the lab?

We use what are called pseudo first -order conditions.

We just overwhelm the system.

We keep the concentration of all reactants, except for the one we're studying, in vast excess.

By doing that, we make sure the rate depends only on the variable reactants concentration.

It simplifies a really complex problem down to a first -order one, which is much easier to analyze.

That makes perfect sense.

And that brings us to how we

quantify this action.

When we assay enzymes, we focus on the initial velocity, $5 a dollar.

Why just the start?

Because we need a clean measurement.

By measuring velocity over a very short time period, we ensure two things.

First, that the substrate concentration hasn't really changed much.

And second, that product hasn't built up enough to start driving the reverse reaction.

Under these clean initial rate conditions, the speed we measure is directly proportional to how much active enzyme you actually have in the sample.

Okay.

Now let's look at that classic graph you see in every kinetics textbook.

As we increase the substrate concentration,

the velocity goes up quickly, but then it just, it hits a maximum plateau, V max off.

A beautiful hyperbolic curve.

It's the hallmark of saturation.

I mean, imagine the active sites of the enzyme are toll booths on a highway.

You start with only a few cars, so the rate goes up linearly, but eventually you have a traffic jam.

Every toll booth is occupied.

Every single one is occupied.

And the rate is Xi max.

At that point, the rate is limited only by how quickly the existing cars can pay their toll and leave so a new car can get in.

You cannot speed it up by adding more cars, only by adding more toll booths, more enzyme.

And the mathematical model for that curve is the Michaelis -Menten equation, which gives us the cornerstone constant of this whole field.

The Michaelis constant, cholerae.

Cholerae is, it's elegantly defined as the substrate concentration you need to achieve exactly half of the maximal velocity, V max 211.

This value, it has the dimensions of concentration and it lets us describe the reaction behavior at any substrate level.

So if I'm looking at a cell where the substrate concentration is much lower than the enzyme's cholermolars, what does that tell me?

That tells you the enzyme is behaving linearly.

It's almost like a first order reaction.

The velocity is super sensitive to every little change in substrate.

And the opposite.

Conversely, if the substrate concentration is massive compared to tollers, the enzyme is saturated.

It's hitting V max and it's acting like a zero order reaction.

Totally insensitive to any more substrate you add.

And a Lawler often gets interpreted as sort of a proxy for the enzyme's affinity for its substrate, correct?

Yes, but with a big caveat.

It may approximate the true binding affinity, the dissociation constant, but only if the complex quickly falls apart back into enzyme and substrate.

Before the chemistry happened.

Right, before the catalytic step.

If the enzyme is super fast at catalysis, then Dahlmacher actually includes information about both binding and chemistry.

And the Dahlmacher's will underestimate the true affinity.

It's best to just view it as the concentration needed for half saturation.

So in the real world, getting to those massive saturating substrate concentrations to really down via backs can be hard or maybe impossible.

So how do researchers get these values precisely?

They use a mathematical trick.

It's called the line weaver Burke plot or the double reciprocal plot.

If you plot the reciprocal of the velocity against the reciprocal of the substrate concentration,

that hyperbolic curve straightens out into a perfect line.

And the beauty of a straight line is that you can accurately extrapolate even if your actual data points don't get you all the way there.

You don't have to guess where the curve flattens.

Exactly.

From this linear plot, you can extract the constants with a great precision.

The point where the line crosses the y -axis gives you five e max.

And where it crosses the x -axis gives one column models.

It's a huge practical advantage.

Okay, beyond column allers and five max.

How do we compare the raw catalytic power of different enzymes like enzyme A versus enzyme B?

Well, for pure enzymes, we look at the catalytic constant K cat.

It's often called the turnover number.

They just V max divided by So it tells you how many molecules one active site can process per second.

Per second, exactly.

But I'm guessing the fastest turnover number isn't necessarily the most efficient enzyme overall, right?

Because it also has to find the substrate first.

You hit the nail on the head.

The best measure of overall efficiency is the ratio of these two values.

Catalytic efficiency, which is gate Km.

This metric weighs the speed of the turnover, the K, against how well it binds, which is related to Galgal abound.

So it answers, how good is this enzyme at finding the substrate and converting it to product?

That's the question it answers.

This leads to that fascinating idea of the catalytically perfect enzyme.

Yeah, for a few rare enzymes,

like trial C phosphate isomerase or carbonic anhydrase, they have evolved to be so fast that the chemical step isn't the rate limiter anymore.

What is?

The only thing limiting them is the physical speed at which the substrate can literally diffuse through the water and bump into the active site.

Their efficiency approaches the theoretical maximum, limited only by physics.

Wow.

Okay, before we jump into the clinical applications of inhibition, we have to look at enzymes that don't follow that nice, simple Michaelis -Menten curve.

Right.

We're talking about cooperative binding, which is an exclusive property of multi -meric enzymes, those made of multiple protein units like hemoglobin.

And their saturation curve is sigmoidal, S -shaped.

An S -shaped, exactly.

And that S -shape tells us there's communication happening between the active sites.

So one binding event affects the others.

It indicates positive cooperativity.

When we analyze this with the Hill equation, we look at the Hill coefficient.

If that number is greater than one, it means when one substrate binds to one unit, it actually enhances the affinity of the remaining units for the substrate.

It's like an all -or -nothing switch.

All right.

Now let's shift focus to inhibitors, because this is where the biochemistry directly translates into drug design.

We classify them based on whether adding more substrate can overcome the effect.

Let's start with the competitive inhibitors.

Competitive inhibitors typically look a lot like the substrate.

They're molecular mimics.

They bind right to the active site, competing directly with the substrate for that prime real estate.

And because it's a competition, their effect can be overcome by just flooding the system with the real substrate.

Kinetically, what does that look like on a Lineweaver -Burk plot?

Well, since you can eventually overcome the inhibition and hit the maximum speed, the Vmax is unchanged.

But it takes more substrate to get halfway there.

So the apparent gallard is increased.

It looks higher.

Okay.

So on the plot?

On the Lineweaver -Burk plot, all the lines will converge at the y -axis, because one Bumax is constant.

This whole mechanism is central to statin drugs, which competitively inhibit HMG -CoA reductase in cholesterol synthesis.

Now compare that to the simple non -competitive inhibitors.

These sound like a very different strategy.

They are.

Non -competitive inhibitors bind at a separate site, not the active site.

Binding the inhibitor doesn't stop the substrate from binding, but when it's on there, it just kills the enzyme's efficiency.

So if it doesn't mess with binding, the gall brower should stay the same?

Precisely.

The gall brower is constant, but because the inhibitor is reducing the overall catalytic power, the Vmax decreases.

When you plot this, the lines all intersect at the x -axis, because one coluborous is constant.

And that's often better for a drug.

It can be, because their effect can't be completely reversed by high substrate levels.

They reduce the total capacity of the machine, no matter how much fuel is available.

Before we move on, we often hear two terms for inhibitor strength, KEEPbino and IC50 dollars.

What's the difference we should focus on?

KEEPbino is the gold standard.

It's the equilibrium dissociation constant for the enzyme inhibitor complex.

It's a rigorous, comparable value.

IC50 dollars, which is the inhibitor concentration causing 50 % inhibition,

is less reliable.

Why is that?

Because its value changes depending on your specific experimental conditions, like how much substrate you used in the test.

KEEPbite is absolute.

Got it.

Let's briefly touch on the more, let's say, aggressive inhibitors.

You have irreversible inhibitors, which are basically chemical poisons like heavy metals that chemically modify the enzyme, usually with covalent bonds, and permanently destroy it.

Then there are the really clever ones.

The mechanism -based, or suicide, inhibitors.

They're brilliant.

They're substrate analogs that are harmless until the enzyme itself starts to work on them.

The enzyme converts the inhibitor into a highly reactive intermediate, which then covalently attacks an essential residue in the active site.

The enzyme literally triggers its own destruction.

We've focused on single substrate reactions, but most biological reactions have multiple substrates.

Let's look at the common bye -bye reactions.

There are two major mechanisms, starting with sequential reactions.

In sequential reactions, all substrates, let's say A and B, they have to bind to the enzyme to form a complex before the chemistry happens.

Okay.

Everything has to be in place first.

Exactly.

We separate these into random order, where A or B can bind first, like in many kinesses, and compulsory order, where one must bind before the other, maybe because that first binding event induces the right shape for the second.

The other major mechanism is the ping -pong reaction.

Right, or double displacement.

This is more like a group transfer.

The key feature is that a product is released before the second substrate has even shown up.

The enzyme is temporarily modified.

It exists in this transient F state, as it carries a piece of the first substrate over to the second one.

If you plot a ping -pong reaction on a Lineweaver -Burk plot,

what's the visual hallmark?

What distinguishes it?

If you plot the reciprocal data for a ping -pong reaction, you get a set of distinct parallel lines.

A parallel pattern is the kinetic signature of a ping -pong mechanism.

You see it a lot in things like aminotransferases.

To wrap up, let's just reinforce the central role kinetics plays in drug development.

If enzymes are the targets, kinetics is the guide for the hunt.

Exactly.

You need kinetic data to define the right screening conditions for finding inhibitors.

If a company screens for a competitive inhibitor using a substrate concentration that's way too high, it'll completely mask the inhibitor's effect.

Even potent drugs will look weak.

And kinetics also impacts drug metabolism, how our body handles the drug once we take it.

Crucially so.

We need drugs that can resist being broken down.

For example, some bacteria produce enzymes called beta -lactamases that destroy antibiotics.

Right, antibiotic resistance.

Exactly.

So to combat that, we often co -administer a beta -lactamase inhibitor along with the antibiotic.

Furthermore, a lot of modern drugs are pro -drugs inactive precursors, like 5 -fluorosil, that require an enzyme in your body to transform them into their active form.

Ah, so you need to know the kinetics of that activating enzyme.

Precisely.

Designing the correct dosage and timing for those requires knowing the kinetics of that transformation inside and out.

What a dense and truly important deep dive into the engine room of biology.

Let's do a quick knowledge check of the key takeaways you really need to hold onto.

First, kinetics, the rate, is fundamentally separate from thermodynamics, which is Gibbs free energy and equilibrium.

Right.

Enzymes lower the activation energy, but they never affect the equilibrium constant.

Second, the Michaelis constant, commollers, is the substrate concentration you need to reach exactly half of the max dollars.

It's the major benchmark for how an enzyme operates.

Third,

for practical purposes, the Lion -Weaver -Burk plot linearizes the data, which lets us estimate vatomax and dollar -dollars precisely from the y and x intercepts.

Fourth,

the ratio kinq -physer is the best measure of overall catalytic efficiency, and for those perfect enzymes, this is limited only by how fast the substrate can physically diffuse to the enzyme.

And fifth, competitive inhibitors increase the apparent cannulators, so the lines intersect on the y -axis, while non -competitive inhibitors decrease vmax, meaning the lines intersect on the x -axis.

Okay, so here's a final thought to leave you with, building on that initial separation of thermodynamics and kinetics.

Since enzymes drastically increase the overall speed of a reaction, but absolutely do not change the final equilibrium point, the enzyme must accelerate the forward reaction rate and the reverse reaction rate by the exact proportional amount to keep that ratio of the equilibrium constant perfectly balanced.

It's an incredible thermodynamic juggling act.

That truly highlights the amazing balancing act enzymes perform every single millisecond inside ourselves.

Thanks for letting us take this deep dive for you.

And we hope this has given you a shortcut to being well informed on this essential topic.

From the Last Minute Lecture Team, thanks for listening.